8-Nov-05 Has finalised an agreement to acquire a 50% equity interest in Celxcel Pty Ltd (“CXC”). bioMD will become the major shareholder and will appoint 2 executive directors to the Board of CXC.
Subscribe today for award-winning, unbiased and trusted journalism